Bryant Furlow

Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared The Lancet, New Scientist, and Oncology Nurse Advisor.

Most Recent Articles by Bryant Furlow

Study Reveals Scope of Genomic Variation Within Cancer Cell Lines

Study Reveals Scope of Genomic Variation Within Cancer Cell Lines

By

Tumor cell lines derived from single cells and curated at different reference labs have quietly evolved in vitro, accumulating distinct genomic aberrations.

BRCA Status Could Inform Pancreatic Cancer Management

BRCA Status Could Inform Pancreatic Cancer Management

By

The development of BRCA-targeted therapies might offer the best opportunities to bring pancreatic cancer into the precision-oncology era.

Do Men Benefit More From Immune Checkpoint Inhibition?

Do Men Benefit More From Immune Checkpoint Inhibition?

By

A meta-analysis of 20 randomized clinical trials found that men may infer a greater benefit from immune checkpoint inhibition.

The International Association for the Study of Lung Cancer Publishes Liquid Biopsy Recommendations

The International Association for the Study of Lung Cancer Publishes Liquid Biopsy Recommendations

By

The IASLC released guidance on the use of biopsies for the detection of EGFR and other tumor mutations in patients with NSCLC.

Is Genomic Medicine Failing Minority Patients?

Is Genomic Medicine Failing Minority Patients?

By

Racial minorities are poorly represented in genomic research databases, raising important questions about whether or not all patients will benefit equally from advances in precision oncology.

More Articles by Bryant Furlow

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs